实用皮肤病学杂志
實用皮膚病學雜誌
실용피부병학잡지
JOURNAL OF PRACTRCAL DERMATOLOGY
2014年
1期
25-27
,共3页
路雪艳%高第%王嵘%王晶%姜薇
路雪豔%高第%王嶸%王晶%薑薇
로설염%고제%왕영%왕정%강미
皮炎,脂溢性%类人胶原蛋白%皮肤屏障
皮炎,脂溢性%類人膠原蛋白%皮膚屏障
피염,지일성%류인효원단백%피부병장
Dermatitis,seborrheic%Human-like collagen%Skin barrier
目的:探讨类人胶原蛋白敷料治疗面部脂溢性皮炎的疗效、安全性及其对皮肤屏障功能的影响。方法将20~50岁女性面部脂溢性皮炎患者67例随机入组,试验组患者外用酮康唑乳膏加类人胶原蛋白敷料,对照组患者单独外用酮康唑乳膏,两组患者均用药10 d,观察皮损变化并测定皮肤屏障功能相关指标。结果第2次随访时,试验组症状积分[(1.06±1.06)分]、经皮水分丢失量(transepidermal water loss,TEWL)[(11.99±5.84) g/(m2μh)]均低于对照组[(1.94±1.17)分、(16.17±8.47) g/(m2μh)],角质层含水量(40.20±11.69)高于对照组(34.13±10.86),差异均有统计学意义(P=0.002,0.024,0.033)。两组患者均未出现明显不良反应。结论类人胶原蛋白敷料治疗成年女性面部脂溢性皮炎,能改善皮肤屏障功能,减轻皮损,可以作为面部脂溢性皮炎的一个安全有效的辅助治疗手段。
目的:探討類人膠原蛋白敷料治療麵部脂溢性皮炎的療效、安全性及其對皮膚屏障功能的影響。方法將20~50歲女性麵部脂溢性皮炎患者67例隨機入組,試驗組患者外用酮康唑乳膏加類人膠原蛋白敷料,對照組患者單獨外用酮康唑乳膏,兩組患者均用藥10 d,觀察皮損變化併測定皮膚屏障功能相關指標。結果第2次隨訪時,試驗組癥狀積分[(1.06±1.06)分]、經皮水分丟失量(transepidermal water loss,TEWL)[(11.99±5.84) g/(m2μh)]均低于對照組[(1.94±1.17)分、(16.17±8.47) g/(m2μh)],角質層含水量(40.20±11.69)高于對照組(34.13±10.86),差異均有統計學意義(P=0.002,0.024,0.033)。兩組患者均未齣現明顯不良反應。結論類人膠原蛋白敷料治療成年女性麵部脂溢性皮炎,能改善皮膚屏障功能,減輕皮損,可以作為麵部脂溢性皮炎的一箇安全有效的輔助治療手段。
목적:탐토류인효원단백부료치료면부지일성피염적료효、안전성급기대피부병장공능적영향。방법장20~50세녀성면부지일성피염환자67례수궤입조,시험조환자외용동강서유고가류인효원단백부료,대조조환자단독외용동강서유고,량조환자균용약10 d,관찰피손변화병측정피부병장공능상관지표。결과제2차수방시,시험조증상적분[(1.06±1.06)분]、경피수분주실량(transepidermal water loss,TEWL)[(11.99±5.84) g/(m2μh)]균저우대조조[(1.94±1.17)분、(16.17±8.47) g/(m2μh)],각질층함수량(40.20±11.69)고우대조조(34.13±10.86),차이균유통계학의의(P=0.002,0.024,0.033)。량조환자균미출현명현불량반응。결론류인효원단백부료치료성년녀성면부지일성피염,능개선피부병장공능,감경피손,가이작위면부지일성피염적일개안전유효적보조치료수단。
Objective To investigate the effect and safety of human-like collagen dressing (HLCD) on facial seborrheic dermatitis and the effect of HLCD on skin barrier function. Methods 67 female outpatients with facial seborrheic dermatitis were randomly classiifed into two groups to be treated with HLCD combined with topical ketoconazole cream (experiment group, n=34) or ketoconazole cream alone (control group, n=33) for ten days. Results Compared with control group, experiment group had significantly lower symptom score and TEWL and higher stratum corneum hydration after ten days treatment (1.06±1.06 vs. 1.94±1.17, 11.99±5.84 vs. 16.17±8.47, 40.20±11.69 vs. 34.13±10.86, t=-3.198,-2.306, 2.185, P=0.002, 0.024, 0.033). No obvious adverse effect was found. Conclusions HLCD could alleviate skin lesion and improve skin barrier function in the treatment of facial seborrheic dermatitis, it could be a good choice for combination therapy of facial seborrheic dermatitis.